Instead, strategies to stabilize the residual protein levels of PEX1 hypomorphs could be modeled on promising approaches to treating other diseases exacerbated by overzealous protein quality control such as cystic fibrosis. This evidence concerns the gene PEX1 and cystic fibrosis.